TFDP2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 6.783000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
7.758200E-01
Normal-vs-Stage2
5.817000E-01
Normal-vs-Stage3
3.141200E-01
Normal-vs-Stage4
1.222210E-01
Stage1-vs-Stage2
6.872000E-01
Stage1-vs-Stage3
6.158000E-02
Stage1-vs-Stage4
3.594000E-02
Stage2-vs-Stage3
5.264100E-02
Stage2-vs-Stage4
9.009700E-02
Stage3-vs-Stage4
5.621700E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
7.829000E-01
Normal-vs-AfricanAmerican
3.749600E-01
Normal-vs-Asian
1.761040E-01
Caucasian-vs-AfricanAmerican
2.775200E-01
Caucasian-vs-Asian
4.223000E-03
AfricanAmerican-vs-Asian
4.118200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
6.966600E-01
Normal-vs-Female
6.579000E-01
Male-vs-Female
9.991200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
8.225200E-01
Normal-vs-Age(41-60Yrs)
3.951000E-01
Normal-vs-Age(61-80Yrs)
8.795000E-01
Normal-vs-Age(81-100Yrs)
5.835600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.459200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.026600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.771800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
8.479200E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
4.862000E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.628800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
9.524200E-01
Normal-vs-Daily Drinker
9.343200E-01
Normal-vs-Weekly Drinker
5.321000E-01
Normal-vs-Occasional Drinker
4.430400E-01
Normal-vs-Social Drinker
6.367800E-01
Non Drinker-vs-Daily Drinker
9.594200E-01
Non Drinker-vs-Weekly Drinker
2.330000E-01
Non Drinker-vs-Occasional Drinker
9.281600E-02
Non Drinker-vs-Social Drinker
3.660600E-01
Daily Drinker-vs-Weekly Drinker
2.730000E-01
Daily Drinker-vs-Occasional Drinker
1.046240E-01
Daily Drinker-vs-Social Drinker
4.141000E-01
Weekly Drinker-vs-Occasional Drinker
4.636600E-01
Weekly Drinker-vs-Social Drinker
8.041600E-01
Occasional Drinker-vs-Social Drinker
3.496000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
5.224200E-01
Normal-vs-Grade 2
5.334200E-02
Normal-vs-Grade 3
7.084000E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.577550E-04
Grade 1-vs-Grade 3
8.22590000000289E-05
Grade 1-vs-Grade 4
5.224200E-01
Grade 2-vs-Grade 3
8.826400E-02
Grade 2-vs-Grade 4
5.334200E-02
Grade 3-vs-Grade 4
7.084000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
6.813400E-01
Normal-vs-NonDiabetic
7.319600E-01
Diabetic-vs-NonDiabetic
8.194800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.045760E-01
Normal-vs-NoPancreatitis
7.704000E-01
Pancreatitis-vs-NoPancreatitis
3.065900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
8.203600E-01
Normal-vs-N1
5.942800E-01
N0-vs-N1
3.578000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.946200E-01
Normal-vs-TP53-NonMutant
9.314000E-01
TP53-Mutant-vs-TP53-NonMutant
4.3591000000065E-05
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
